MIST II study
This article was originally published in The Gray Sheet
Executive Summary
NMT Medical receives an investigational device exemption to conduct a double-blind, randomized trial to assess migraine headache prevention by using the STARFlex septal repair implant to close the patent foramen ovale (PFO). The announcement comes roughly one month after rival St. Jude received clearance to begin enrollment for a study using its Premere PFO closure device 1("The Gray Sheet" Aug. 29, 2005, p. 12)...